Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Insect detoxification enzymes are a broad collective group of proteins, primarily comprising Cytochrome P450 monooxygenases (CYPs), Glutathione S-transferases (GSTs), and Carboxylesterases (CarEs), that facilitate the biotransformation and elimination of exogenous toxic substances [5, 10]. These enzymes are organized into a multi-phase system where Phase I enzymes (P450s and CarEs) introduce or expose polar groups through oxidation or hydrolysis, and Phase II enzymes (GSTs and UGTs) conjugate these metabolites to hydrophilic molecules for excretion [8, 11]. In insects, these enzymes are the fundamental drivers of metabolic resistance to insecticides, as their overexpression or mutation allows pests to rapidly neutralize chemical agents before they reach their physiological targets [4, 16]. While not primary human therapeutic targets, they are essential targets in agriculture and public health for the development of synergists like piperonyl butoxide, which inhibit these enzymes to enhance insecticide efficacy and manage vectors of diseases such as malaria [1, 13]. However, because many of these metabolic pathways are conserved across insect species, a major therapeutic challenge is minimizing off-target toxicity to beneficial pollinators like honey bees, which may possess similar but less diverse enzyme systems [13, 20]. Understanding and monitoring the activity of these enzymes is therefore critical for integrated pest management and the prevention of vector-borne disease outbreaks.
Inhibition of metabolic degradation by chemical synergists (competitive or irreversible inhibition) to restore insecticide susceptibility or the use of pro-insecticides that require enzymatic activation.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Insect detoxification enzymes.